Cargando…
PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS.
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429891/ http://dx.doi.org/10.1097/01.HS9.0000974268.66479.a1 |
| _version_ | 1785090824349941760 |
|---|---|
| author | Lessi, Federica Borlenghi, Erika Sartor, Chiara Vetro, Calogero Audisio, Ernesta Vincenzo, Federico Visentin, Andrea Loscocco, Federica Gurrieri, Carmela Trentin, Livio Ferrara, Felicetto |
| author_facet | Lessi, Federica Borlenghi, Erika Sartor, Chiara Vetro, Calogero Audisio, Ernesta Vincenzo, Federico Visentin, Andrea Loscocco, Federica Gurrieri, Carmela Trentin, Livio Ferrara, Felicetto |
| author_sort | Lessi, Federica |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429891 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104298912023-08-17 PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. Lessi, Federica Borlenghi, Erika Sartor, Chiara Vetro, Calogero Audisio, Ernesta Vincenzo, Federico Visentin, Andrea Loscocco, Federica Gurrieri, Carmela Trentin, Livio Ferrara, Felicetto Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429891/ http://dx.doi.org/10.1097/01.HS9.0000974268.66479.a1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Lessi, Federica Borlenghi, Erika Sartor, Chiara Vetro, Calogero Audisio, Ernesta Vincenzo, Federico Visentin, Andrea Loscocco, Federica Gurrieri, Carmela Trentin, Livio Ferrara, Felicetto PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title | PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title_full | PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title_fullStr | PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title_full_unstemmed | PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title_short | PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. |
| title_sort | pb1858: prognosis and treatment of flt3 mutated myeloid sarcoma in the era of flt3 inhibitors: retrospective evaluation in 5 italian centers. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429891/ http://dx.doi.org/10.1097/01.HS9.0000974268.66479.a1 |
| work_keys_str_mv | AT lessifederica pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT borlenghierika pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT sartorchiara pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT vetrocalogero pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT audisioernesta pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT vincenzofederico pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT visentinandrea pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT loscoccofederica pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT gurriericarmela pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT trentinlivio pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters AT ferrarafelicetto pb1858prognosisandtreatmentofflt3mutatedmyeloidsarcomaintheeraofflt3inhibitorsretrospectiveevaluationin5italiancenters |